Human Papillomavirus Infection and Virus Genotyping in Uterine Cervix Cancer in Venezuela

NCT00937547 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 329

Last updated 2012-12-04

Study results available
· View outcomes & findings →

Summary

1. Hypothesis:

If high risk genotypes of human papillomavirus (HPV) is the cause of cervical cancer worldwide, the genotypes associated with cervical cancer in Venezuela would be the same types found in other countries.
2. Objectives:

Primary objective:

The objective of this investigation is to determine the presence and genotypes of HVP infection in cervical intraepithelial neoplasia grade 2/3 (CIN 2/3), and Stage I cervical epidermoid carcinoma and cervical adenocarcinoma.

Specific objectives:

To establish the presence of HPV in cervical cancer patients in Venezuela by geographic distribution.

To establish which HPV types are linked with cervical cancer in Venezuela by geographic distribution.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Jorge sanchez, MD · Instituto Oncologico Luis Razetti

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • Venezuela

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00937547 on ClinicalTrials.gov